SMOORE Launches the World’s Thinnest Ceramic Coil Vape Pod Solution FEELM Air
SMOORE, the world's largest vaping manufacturer, today launches the world’s thinnest ceramic coil vape pod solution - FEELM Air at its New Technology Launch Event in London. FEELM Air features 7 major breakthroughs in vaping experience, including ultimate design, reliability, flavor and joyful interactive experience.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220118005508/en/
FEELM Air: World's Thinnest Ceramic Coil Vape Pod Solution (Photo: Business Wire)
The comprehensive improvement of FEELM Air is attributed to the new generation of Ultra-slim Bionic Film Ceramic Coil, which is created with 3 revolutionary innovations.
3 Innovations on Ultra-slim Bionic Film Ceramic Coil
Firstly, it has the world's first 7-layer composite heating film made of bionic material, with each layer leading to a correspondingly enhanced functionality.
Secondly, the new bionic ceramic coil leverages Nanoscale Vacuumed Film-forming Technique to make the heating film distributed more evenly, for accurate temperature distribution.
Thirdly, it features a microporous bionic structure to provide smooth ventilation as well as strong leakage-proof performance.
7 Breakthroughs in vaping experience brought by FEELM Air
Underpinned by Ultra-slim Bionic Film Ceramic Coil, FEELM Air manages to achieve 7 major breakthroughs.
Most importantly, FEELM Air improves an overall harm reduction performance by 80%, compared with last generation. Hybrid Composites Heating Layer and the industry's first Nanoscale Protection Layer with corrosion resistance reduce the emission of heavy metals by 78.6%; and Temperature Control Layer with thermal conductivity can reduce the emission of Aldehydes and Ketones by 80.7% due to localized over-heating, compared with last generation.
The second breakthrough is more authentic flavor reproduction. FEELM Air employs the exclusive and patented Flavor-Lock™ technology, which improves average flavor release by 33%. Moreover, terraced temperature zone and multi-layered atomization of the ceramic coil allow tailored flavor release in different temperature zones. Microporous Flavor-Lock™ Layer produces aerosols in smaller particle size for consumers to taste the flavor thoroughly.
Thirdly, FEELM Air features an excellent leakage-proof performance. It utilizes 2nd Generation of “Puzzle leakage-proof” technology, decreasing leakage rate by 237%, by means of capillary structure and an innovative choke valve to prevent condensation. Besides, Superabsorbent Lock Layer can effectively prevent e-liquid splashing.
In terms of energy optimization, FEELM Air boasts the world's highest energy efficiency of 1.3mg/W, by virtue of three layers of composite materials. Temperature Control Layer allows the heating film to form a proper terraced temperature zone. Nano Silver Electro Layer can reduce invalid energy consumption while Porous Thermal Resistance Layer can effectively reduce heat loss.
The fifth breakthrough is mounting the world's smallest linear motor, which offers a unique "Shock-wave Mode", bringing users delicate vibrations and interactive vaping experience, so that the user can feel the resonance in every puff. The power consumption of vibrations per charge is as low as 0.06%, which is equal to only two puffs.
Meanwhile, FEELM Air has industry's first super power management system “TOPOWER™”, which allows 10-minute charge for 8-hour vaping. In contrast to the last generation, the system’s energy density is increased by 20% and battery life is increased by 30%.
Finally, FEELM Air adopts an integrated MEMS (Micro-electro Mechanical Systems), which functions as a reliable airflow switch, to improve the sensitivity of the device while preventing mis-activation.
"FEELM Air is an outcome of cross-disciplinary research, and a revolutionary innovation to ceramic coil, " said Frank Han, President of FEELM at opening remark of the launch event. "It upgrades the current single-layer film to a 7-layer biotic thin film. The thickness of the film is reduced from 80 micrometers to 2 micrometers, which is 40 times thinner than the last generation."
FEELM Brand Refresh
In addition, Frank Han announced the brand refresh of FEELM at the launch event. The new brand concept is composed of five words: Feel, Engine, Exploration, Lifestyle and Memory, echoing the five letters of the brand name FEELM. He also unveiled new FEELM logo, which has the contour of ceramic coil and is in a shape of window, symbolizing FEELM’s Window to Ultimate Sensation. The “open window” stands for the infinite pursuit of a better sensory experience, representing FEELM’s commitment to ultimate sensation.
Ever since the launch of the world’s first black ceramic atomization coil with metallic film in 2016, FEELM has changed the whole competitive landscape, ushering in a new era of ceramic coil. It has largely enhanced harm reduction with accurate heating temperature control and revolutionized vaping experience with smooth and pure taste till the last puff. More importantly, FEELM has effectively addressed the industry’s pain points of leakage and dry hit.
By 2022, vaping devices loaded with FEELM atomizers have been exported to over 50 countries in Europe, America, East Asia, Africa, and Oceania, with its accumulated sales volume of over 3 billion pieces. FEELM has never stopped the constant exploration for ultimate sensation. By virtue of FEELM Air, equipped with Ultra-slim Bionic Film Ceramic Coil, FEELM is ready to drive another paradigm shift in the global vaping industry, leading the second sensory revolution of ultra-slim device and ceramic coil.
About FEELM
FEELM tech is a high-quality pod system solution belonging to SMOORE, based on the world's leading ceramic coil heating technology. Combing with flavor reproduction technology and innovative electronics technology and structure design, bringing ultimate sensation and premium vaping experience to global vapers. Focusing on the research of cutting-edge atomization technology, FEELM provides vape brands with total solutions and manufacturing. Now FEELM symbol is on the vape pods of market-leading vaping brands around the world, such as RELX, NJOY, Haka, and VAPO.
About SMOORE
SMOORE is a global leader in offering vaping technology solutions, including manufacturing vaping devices, and vaping components, with advanced R&D technology, strong manufacturing capacity, wide-spectrum product portfolio and diverse customer base. The Company is the world’s largest vaping device manufacturer in terms of revenue, accounting for 18.9% of the total global market share.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220118005508/en/
Contact information
Frankie Chen
Email: frankie.chen@smoorecig.com
Phone: (+86) 13530848319
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Medicines Granted U.S. FDA Fast Track Designation for BGB-B2033 as Treatment for Hepatocellular Carcinoma18.12.2025 12:00:00 CET | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has granted the Company Fast Track Designation for BGB-B2033, its GPC3x4-1BB bispecific antibody for the treatment of adult patients with hepatocellular carcinoma (HCC) with disease progression on or after prior systemic treatment. “The FDA awards Fast Track Designation to therapies that show potential to address an unmet medical need in serious or life-threatening conditions. The FDA’s decision reflects the encouraging profile of BGB-B2033 in advanced hepatocellular carcinoma, where patients continue to face limited treatment options,” said Julie Lepin, Senior Vice President and Chief Regulatory Affairs Officer at BeOne. BeOne is currently conducting a global, multi-center Phase 1 clinical trial (NCT06427941) to explore the safety and anti-tumor activity of BGB-B2033, both alone and in combination with PD-1 inhibitor TEVIMBRA® (tisle
NHOA Energy Achieves Great Place To Work Certification in Italy, the United States and Australia18.12.2025 10:53:00 CET | Press Release
NHOA Energy, global provider of utility-scale energy storage systems, announces that it has been certified Great Place To Work® in Italy, the United States, and Australia. The certification is based entirely on direct feedback from NHOA Energy employees, gathered through an independent and structured listening process. Great Place To Work® Certification™ assesses the quality of the employee experience across key dimensions such as credibility, respect, fairness, pride, and camaraderie. The results achieved by NHOA Energy reflect a corporate culture built on trust, inclusion, and the consistent commitment to valuing people within a dynamic and international environment. Employees highlighted particularly high levels of appreciation for the ethical and transparent behavior of leaders, the welcoming and inclusive approach toward new hires, and fair treatment across diversity, equity, and inclusion dimensions. A strong majority also expressed pride in working at NHOA Energy and reported a
Regnology Signs an Agreement to Acquire Moody’s Regulatory Reporting & ALM Solutions18.12.2025 10:00:00 CET | Press Release
Regnology, a leading provider in regulatory, risk, tax, and finance reporting, as well as supervisory technology, today announced it has signed an exclusive agreement for the acquisition of Moody’s Regulatory Reporting & ALM Solutions business, inclusive of solutions for Basel III compliance, IFRS9 impairment accounting, large bank asset-liability management (ALM), Solvency II insurance reporting, and prudential and statistical regulatory reporting across more than 50 jurisdictions. By integrating Moody’s regulatory capital and liquidity capabilities with Regnology’s regulatory, risk, and finance offerings, the firm is creating a unified, scalable platform designed to meet the full spectrum of financial regulatory compliance and risk requirements. This combined strength positions Regnology as the partner of choice for financial institutions seeking future-ready solutions. At the core of this strategy is Regnology Risk Hub (RRiskHub), an integrated solution designed to deliver a single
Reply Recognized as a Microsoft Azure Expert Managed Services Provider for the Sixth Consecutive Year18.12.2025 10:00:00 CET | Press Release
Reply [EXM, STAR: REY] announced today it has been recognized once again as a Microsoft Azure Expert Managed Services Provider (MSP). The renewal reaffirms Reply’s proven expertise and consistent track record in delivering high-quality cloud solutions and services on the Microsoft Azure platform, powered by the deep technical expertise of its specialized companies – Cluster Reply, Solidsoft Reply and Valorem Reply. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218596617/en/ This recognition reflects the ongoing collaboration between Reply - through its companies Cluster Reply, Solidsoft Reply, and Valorem Reply - and Microsoft, supporting shared efforts to deliver value-driven services to enterprise customers. The Azure Expert MSP program is designed by Microsoft to identify and validate partners with proven capabilities in delivering end-to-end Azure services at scale. To qualify, partners must meet a strict set of requ
Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment18.12.2025 09:00:00 CET | Press Release
Takeda(TSE:4502/NYSE:TAK)today announced positive topline results for the two pivotal Phase 3randomized, multicenter, double-blind, placebo- and active comparator-controlled studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO). The studies demonstrated superiority of zasocitinib compared to placebo for the co-primary endpoints, static Physician Global Assessment (sPGA) 0/1 and Psoriasis Area and Severity Index (PASI) 75, at week 16, with a significantly greater PASI 75 response rate seen as early as week 4 and continuing to increase through week 24. The studies also met all 44 ranked secondary endpoints, including PASI 90, PASI 100 and sPGA 0 against placebo and apremilast, showing the potential of a convenient once-daily pill to deliver complete skin clearance for patients with PsO. “People living with psoriasis continue to seek safe, effective and fast-acting oral therap
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom